office, Munchang Campus), Objectives: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation and irreversible airflow. This study aimed to evaluate the effects of GHX02 in a COPD-induced mouse model. Methods: The COPD mouse model was established by exposure to cigarette smoke extract and lipopolysaccharide which were administered by intratracheal injection three times with a 7 day interval. GHX02 (100, 200, 400 mg/kg) and all other drugs were orally administrated for 14 days from Day 7 to Day 21. Results: GHX02 significantly decreased the neutrophil counts in bronchoalveolar lavage fluid (BALF) and the number of CD4 + , CD8 + , CD69 + , and CD11b + /GR1 + cells in BALF and lung cells. GHX02 also suppressed the secretion of tumor necrosis factor-alpha (TNF-α), interleukin-17A, macrophage inflammatory protein 2 (MIP2), and chemokine (C-X-C motif) ligand 1 (CXCL-1) in BALF and ameliorated the lung pathological changes. Conclusions: Thus, GHX02 effectively inhibited airway inflammation by inhibiting migration of inflammatory cells and expression of pro-inflammatory cytokines. Therefore, GHX02 may be a promising therapeutic agent for COPD.
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide and is predicted to be the 3rd leading cause of death in 2020, due to high smoking rates, air pollution, and an increase in the elderly population 1) . It is characterized by chronic inflammation and airflow limitation that is usually progressive and irreversible caused by environmental exposure to cigarette smoke, air pollution and various particles or gases 2) . Cigarette smoke contains reactive oxygen species (ROS) and many other chemical components, which triggers the release of chemoattractants, promoting the recruitment of neutrophils and other inflammatory cells 3),4) . This non-specific immune system mediates the processes of inflammation, fibrosis and proteolysis 5) . In particular, an increase in neutrophils is associated with development of COPD and has been observed in bronchoalveolar lavage fluid (BALF) and sputum 6) . Current conventional treatment for COPD is based on bronchodilators according to present guidelines 7) , although it has limitations in reducing inflammation of the lung and promoting lung functions 8) . Corticosteroids are also widely used for COPD patients despite its resistance 9) and high risk of side effects such as skin bruising, reduction of bone density, etc 10) . Thus, the need for alternative treatments such as herbal medicines has been increased 11) and several herbal medicines including socheongryong-tang 12) , maekmoondong-tang 13) , chungsangboha-tang 14) , sagan-tang 15) and gwaruhaengryeon-hwan 16) have been studied for COPD patients.
In this study, we developed herbal medicine, GHX02, which contains four herbs originated from gwaruhaengryeon-hwan (GRHRH) in Donguibogam (Principles and Practice of Eastern Medicine) 17) and planned to evaluate anti-inflammatory effects of GHX02 on COPD-induced mice. GHX02 was formed by adding Scutellariae Radix to GRHRH. GRHRH already demonstrated its anti-inflammatory effects on COPD and particulate matter induced lung injury on a mouse model 16) and previous studies reported that Scutellariae Radix inhibits the production of several inflammatory cytokines 18) and has antioxidant effects 19) .
We first established COPD mouse model by exposure to the cigarettes smoke extract (CSE) and lipopolysaccharide (LPS). Then, flow cytometric analysis, Enzyme-linked immunosorbent assays (ELISA) and lung histopathological study was done to assess the immunotherapeutic potential of GHX02. .
Materials and Methods
The animal protocol was approved by the committee .
Data are expressed as the mean ± standard error and analyzed using a one-way analysis of variance. 
Results
To evaluate the effects of GHX02 on the recruitment of cells to the airway, we investigated neutrophils in BALF as neutrophil mediated inflammation plays an important role in the development and pathogenesis of COPD 23) . The number of neutrophils was significantly higher in the BALF cytospin of the COPD-induced mice (CSE+LPS) than in that of untreated group (C57BL/6_Nr) (Fig. 2) Flow cytometric analysis was used to evaluate the effects of GHX02 on immune cell subtypes 24) . The numbers of CD4 + , CD8 + , CD69 + , and CD11b + /GR1 + cells in the BALF and lungs of the COPD-induced mice were significantly higher than those in the untreated group and were significantly lower in the GHX02-treated mice than in the control mice (Table   2 ). Thus, GHX02 showed profound inhibitory effects on airway inflammation in the mouse model of COPD, and these effects were caused by suppression of Th2-type cytokines and neutrophil infiltration.
We measured the levels of COPD-accompanying cytokines in BALF to determine the mechanisms underlying the GHX02-mediated inhibition of airway inflammation. In mice exposed to CSE and LPS, the levels of TNF-α, IL-17A, MIP2, and CXCL-1 in BALF were significantly higher than those in the untreated group. However, administration of GHX02 and individual herbs of TS, AS, SR, CR significantly suppressed the increases in TNF-α, IL-17A, MIP2, and CXCL-1 in BALF compared with those in the COPD-induced untreated mice (Fig. 3 ). The inhibitory This result indicates that the COPD model was successfully established and GHX02 obviously improved the pathological injury of COPD (Fig. 4B ).
Discussion
In the circumstances that the worldwide prevalence of COPD has substantially increased and no direct treatment has yet been developed 25) , various herbal GHX02 also suppresses the increase of the pro-inflammatory cytokines, TNF-α and IL-17. TS, AS, CR and SR also showed inhibitory effects on TNFα and AS, CR showed effects on IL-17. Cigarette smoke can activate macrophages to produce TNF-α and is measured in large quantities in COPD, especially during exacerbations. TNF-α induces the gene expression of many pro-inflammatory cytokines via NF-κB transcription factor activation 28) . Interleukin (IL)-17A correlates with the presence of neutrophils and the severity of loss of lung function. IL-17A plays a critical role for the innate immune response through its ability to indirectly mobilize neutrophils, promoting airway neutrophils through the induction of granulocyte chemokines and growth factors 29) . Therefore, GHX02 is considered to have an inhibitory effect on neutrophil-related and CXCL-1 secretion. GHX02 and SR significantly suppressed the increases in CXCL-1 and MIP2 was decreased in treatment with GHX02 and AS, SR, CR.
CXCL-1 is known to increase in the sputum of patients with COPD, and CXCL-1 and MIP2, which mainly secreted from macrophages, are reported to accumulate neutrophil and other inflammatory cells into lesions 30) .
Overall, GHX02 exhibited anti-inflammatory effects by inhibiting migration of inflammatory cells and expression of pro-inflammatory cytokines in a COPD mouse model. This anti-inflammatory effect could also be demonstrated by the result that GHX02 markedly attenuated the damage of lung.
This study provides evidence that the treatment of GHX02 and individual herbs exert preventive and therapeutic effects against COPD mouse model. Among individual herbs, CR significantly showed inhibitory effect on airway neutrophil accumulation and SR decreased the level of CXCL-1 effectively. Our results are consistent with previous reports indicating anti-inflammatory effects of GRHRH 16) and as well as TS 31) , AS 32) , CR 33),34) , SR 18) . These data demonstrated that GHX02 may be a promising strategy for treatment of COPD. Further studies to discover the therapeutic mechanisms of GHX02 and clinical trials for COPD patients will be conducted.
